University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital
Search Site | Find a Doctor

Jeffrey A. Golden, M.D.

Medical director of the Lung Transplantation Program

Dr. Jeffrey Golden, medical director of Lung Transplantation, is a pulmonologist who treats patients with severe lung disease, particularly candidates for lung transplants. In addition, he is director of the Bronchoscopy Service, medical director of the Advanced Lung Disease Program and director of clinical trials for the Interstitial Lung Disease Program.

Golden earned a bachelor's degree at Yale University and a medical degree at Washington University in St. Louis in 1972. He completed internal medicine and pulmonary training at UCSF. He completed pulmonary research training at UCSF's Cardiovascular Research Institute where he studied ozone inhalation in humans as a model of asthma. He is a professor of clinical medicine at UCSF.

Conditions & Treatments

Clinics

Chest Clinic
400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143-0359
Phone: (415) 353-2961
Fax: (415) 353-2568

Hours: Monday to Friday
8 a.m. – 5 p.m.

Interstitial Lung Disease Program
400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143
Phone: (415) 353-2577
Fax: (415) 353-2568

Hours: Friday
8 a.m. – noon

Lung Transplant Program
400 Parnassus Ave., Sixth Floor
San Francsico, CA 94143
Phone: (415) 353-4145
Fax: (415) 353-4166

Hours: Thursday 8 a.m. – 5 p.m. (exact times vary depending on number of physicians in clinic)

More about Jeffrey A. Golden

Education

Washington University School of Medicine 1972

Residencies

UCSF Medical Center, Internal Medicine 1975

Fellowships

UCSF Medical Center, Pulmonary Medicine 1977

Selected Research and Publications

  1. Moore KD, Chen R, Cilluffo M, Golden JA, Phelps PE. Lis1 reduction causes tangential migratory errors in mouse spinal cord. J Comp Neurol. 2012 Apr 15; 520(6):1198-211.
  2. Schrier SA, Wong LJ, Place E, Ji JQ, Pierce EA, Golden J, Santi M, Anninger W, Falk MJ. Mitochondrial tRNA-serine (AGY) m.C12264T mutation causes severe multisystem disease with cataracts. Discov Med. 2012 Feb; 13(69):143-50.
  3. Cho G, Nasrallah MP, Lim Y, Golden JA. Distinct DNA binding and transcriptional repression characteristics related to different ARX mutations. Neurogenetics. 2012 Feb; 13(1):23-9.
  4. Watkins KD, Boettger RF, Hanger KM, Leard LE, Golden JA, Hoopes CW, Singer JP. Use of sublingual tacrolimus in lung transplant recipients. J Heart Lung Transplant. 2012 Feb; 31(2):127-32.
  5. Smith L, Singer JP, Hayes M, Golden JA, Leard LE. An analysis of potential risk factors for early complications from fiberoptic bronchoscopy in lung transplant recipients. Transpl Int. 2012 Feb; 25(2):172-8.
  6. Nasrallah MP, Cho G, Simonet JC, Putt ME, Kitamura K, Golden JA. Differential effects of a polyalanine tract expansion in Arx on neural development and gene expression. Hum Mol Genet. 2012 Mar 1; 21(5):1090-8.
  7. Singer JP, Chen H, Phelan T, Kukreja J, Golden JA, Blanc PD. Survival following lung transplantation for silicosis and other occupational lung diseases. Occup Med (Lond). 2012 Mar; 62(2):134-7.
  8. Hayes D, Golden JA, Hoopes CW. Refractory bilateral pneumothoraces in end-stage cystic fibrosis. Ann Thorac Surg. 2011 Nov; 92(5):1905.
  9. Mastracci TL, Wilcox CL, Arnes L, Panea C, Golden JA, May CL, Sussel L. Nkx2.2 and Arx genetically interact to regulate pancreatic endocrine cell development and endocrine hormone expression. Dev Biol. 2011 Nov 1; 359(1):1-11.
  10. Singer JP, Blanc PD, Hoopes C, Golden JA, Koff JL, Leard LE, Cheng S, Chen H. The impact of pretransplant mechanical ventilation on short- and long-term survival after lung transplantation. Am J Transplant. 2011 Oct; 11(10):2197-204.
  11. Judkins AR, Martinez D, Ferreira P, Dobyns WB, Golden JA. Polymicrogyria includes fusion of the molecular layer and decreased neuronal populations but normal cortical laminar organization. J Neuropathol Exp Neurol. 2011 Jun; 70(6):438-43.
  12. Ara J, Fekete S, Frank M, Golden JA, Pleasure D, Valencia I. Hypoxic-preconditioning induces neuroprotection against hypoxia-ischemia in newborn piglet brain. Neurobiol Dis. 2011 Aug; 43(2):473-85.
  13. Pluskota E, Dowling JJ, Gordon N, Golden JA, Szpak D, West XZ, Nestor C, Ma YQ, Bialkowska K, Byzova T, Plow EF. The integrin coactivator kindlin-2 plays a critical role in angiogenesis in mice and zebrafish. Blood. 2011 May 5; 117(18):4978-87.
  14. Lysko DE, Putt M, Golden JA. SDF1 regulates leading process branching and speed of migrating interneurons. J Neurosci. 2011 Feb 2; 31(5):1739-45.
  15. Cho G, Lim Y, Golden JA. XLMR candidate mouse gene, Zcchc12 (Sizn1) is a novel marker of Cajal-Retzius cells. Gene Expr Patterns. 2011 Mar-Apr; 11(3-4):216-20.
  16. Tan JH, Fidelman N, Durack JC, Hays SR, Leard LL, Laberge JM, Kerlan RK, Golden JA, Gordon RL. Management of recurrent airway strictures in lung transplant recipients using AERO covered stents. J Vasc Interv Radiol. 2010 Dec; 21(12):1900-4.
  17. Golden JA, Harding BN. Cortical malformations: unfolding polymicrogyria. Nat Rev Neurol. 2010 Sep; 6(9):471-2.
  18. Conte JE, DeVoe C, Little E, Golden JA. Steady-state intrapulmonary pharmacokinetics and pharmacodynamics of posaconazole in lung transplant recipients. Antimicrob Agents Chemother. 2010 Sep; 54(9):3609-13.
  19. Walsh TJ, Goutelle S, Jelliffe RW, Golden JA, Little EA, DeVoe C, Mickiene D, Hayes M, Conte JE. Intrapulmonary pharmacokinetics and pharmacodynamics of micafungin in adult lung transplant patients. Antimicrob Agents Chemother. 2010 Aug; 54(8):3451-9.
  20. Kinder BW, Shariat C, Collard HR, Koth LL, Wolters PJ, Golden JA, Panos RJ, King TE. Undifferentiated connective tissue disease-associated interstitial lung disease: changes in lung function. Lung. 2010 Apr; 188(2):143-9.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.